3Sackett D L,Rosenberg W M.The need for evidence-based med icine[J].J R Soc Med,1995,88:620-624.
4Sackett D L,Richardson W S,Rosenberg W,et al.Evidence-based medicine how to practice & te ach EBM[M].New York:Churchill Livingstone Inco,1997.91-96.
6John M L,Bruce A M,James D M,et al.Ineffectiveness of highdose methylprednisolone in preventing parenchymal lung injury and improv ing mortality in patients with septic shock[J].Am Rev Respir Dis,1988,136:62 -68.
7Milberg J A,Davis D R,Steinberg K P,et al.Improved surviva l of patients with acute respiratory distress syndrome (ARDS):19831993[J].JAMA,1995,273:306-309.
8Meduri G U,Headley A S,Golden E,et al.Effect of prolonged methyprednisolone therapy in unresol ving acute respiratory distress syndrome:a randomized controlled trial[J].JAM A,1998,280:159-165.
9Rossi A,Roussoc C.The role of the host defence and outcome of ARDS :pathophysiological correlations and reponse to glucocorticoid treatment[J].E ur Respir,1996,9:2650.
10Begg C,Cho M ,Eastwood S.Improving the quality of reporting of randomized trials[J].JA MA,1996,276(8):637-639.
